Connecting Sign in

Insider trades appear within seconds, the rest within the hour.

Get alerts

← Feed

PHATNasdaq

Phathom Pharmaceuticals, Inc.

Alert me on PHAT
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

After each filing

2
Nov 6, 2025 Sale Breedlove Robert Charles Insider
1 week
+13.9%S&P +0.3%
1 month
+14.3%S&P +2.0%
3 months
−2.0%S&P +3.8%
6 months
−6.3%S&P +10.9%
Sep 10, 2025 Sale Breedlove Robert Charles Insider
1 week
−10.7%S&P +1.1%
1 month
−5.5%S&P +3.2%
3 months
+15.3%S&P +5.0%
6 months
−17.0%S&P +2.7%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for PHAT

39 held · newest 539 held · newest 2
Loading the filings.
See all 39 filings for PHAT

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
$15KQ4 2025
$15KQ1 2026
$15KQ2 2026
$15KQ3 2026
Unchanged from Q2 2026. Reported to the Senate each quarter by the firms it hires.Original report ↗

Read from LDA.gov between Sep 23, 2026 and Oct 20, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.